Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NK/T Cell Lymphoma: A Tertiary Centre Experience.
Arora N, Mehta A, Ravichandran S, Arun I, Achari RB, Chakrapani A, Bhave SJ, Chandy M, Nair R. Arora N, et al. Among authors: achari rb. Indian J Hematol Blood Transfus. 2017 Mar;33(1):69-73. doi: 10.1007/s12288-016-0675-x. Epub 2016 Apr 21. Indian J Hematol Blood Transfus. 2017. PMID: 28194059 Free PMC article.
Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature Review.
Radhakrishnan VS, Bajaj R, Raina V, Kumar J, Bhave SJ, Sukumaran Nair RK, Nag A, Arun I, Zameer L, Dey D, Arora N, Parihar M, Das J, Achari RB, Mishra DK, Chandy M, Nair R. Radhakrishnan VS, et al. Among authors: achari rb. Front Oncol. 2022 Jan 21;11:796270. doi: 10.3389/fonc.2021.796270. eCollection 2021. Front Oncol. 2022. PMID: 35127505 Free PMC article.
Salvage Using Polatuzumab Vedotin Based Therapy in Relapsed Refractory Large B-Cell Lymphomas: Early Experience from a Real-World Middle-Income Setting Using Named-Patient Compassionate Access Program.
Radhakrishnan VS, Pincha R, Raina V, Garg JK, Nag A, Bhave SJ, Achari R, Dey D, Arun I, Lateef Z, Vinarkar SS, Parihar M, Sen S, Mishra DK, Chandy M, Nair R. Radhakrishnan VS, et al. Indian J Hematol Blood Transfus. 2022 Dec 25;39(4):1-5. doi: 10.1007/s12288-022-01619-w. Online ahead of print. Indian J Hematol Blood Transfus. 2022. PMID: 36590655 Free PMC article.
Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center.
Shrimali RK, Nallathambi C, Saha A, Das A, Prasath S, Mahata A, Arun B, Mallick I, Achari R, Dabkara D, Thambudorai R, Chatterjee S. Shrimali RK, et al. Indian J Cancer. 2018 Apr-Jun;55(2):125-133. doi: 10.4103/ijc.IJC_469_17. Indian J Cancer. 2018. PMID: 30604722 Free article.
Actual gains in dosimetry and treatment delivery efficiency from volumetric modulated arc radiotherapy for inoperable, locally advanced lung cancer over five-field forward-planned intensity-modulated radiotherapy.
Shrimali RK, Arunsingh M, Reddy GD, Mandal S, Arun B, Prasath S, Sinha S, Mallick I, Achari R, Chatterjee S. Shrimali RK, et al. Indian J Cancer. 2017 Jan-Mar;54(1):155-160. doi: 10.4103/ijc.IJC_79_17. Indian J Cancer. 2017. PMID: 29199680 Free article.
46 results